Evidence map›Paper›PMID 28536106›Full record

ArticleMolecular pharmacology2017

A Kerstin Lindemeyer, Yi Shen, Ferin Yazdani, Xuesi M Shao, Igor Spigelman, Daryl L Davies, Richard W Olsen, Jing Liang

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Modulation of neuronal excitability by binge alcohol drinking.Frontiers in molecular neuroscience · 2023
    Review
  4. Article
  5. Article
  6. Regulation of GABAInternational journal of molecular sciences · 2020
    Review
  7. Article
  8. Nucleus accumbens shell small conductance potassium channels underlie adolescent ethanol exposure-induced anxiety.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  9. Article
  10. GABANeuropharmacology · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Role of GABAMolecular brain · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

A Kerstin LindemeyerDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California AKLindemeyer@mednet.ucla.edu lian743@usc.edu.
Yi ShenDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California.
Ferin YazdaniDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California.
Xuesi M ShaoDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California.
Igor SpigelmanDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California.
Daryl L DaviesDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California.
Richard W OlsenDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California.
Jing LiangDepartment of Molecular and Medical Pharmacology (A.K.L., Y.S., F.Y., R.W.O., J.L.), and Department of Neurobiology (X.M.S.), David Geffen School of Medicine at University of California at Los Angeles, and Division of Oral Biology and Medicine, School of Dentistry (I.S.), University of California and Titus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy (D.L.D., J.L.), Los Angeles, California AKLindemeyer@mednet.ucla.edu lian743@usc.edu.
University of California, Los Angeles · USUniversity of Southern California · US

Funding

Regulation of Alcohol Intake by Purinergic P2X4 ReceptorsR01AA022448 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DAVIES, DARYL L · 2013 to 2020
$2.9M
GABA RECEPTOR COMPLEX IN ALCOHOL DEPENCENCER37AA007680 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OLSEN, RICHARD W · 1998 to 2006
$1.8M
GABA RECEPTOR COMPLEX IN ALCOHOL DEPENDENCER01AA007680 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OLSEN, RICHARD W · 1988 to 2012
$1.8M
Mechanisms of GABAA Receptor Plasticity in AlcoholismR01AA016100 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPIGELMAN, IGOR · 2007 to 2011
$1.7M
Unique pharmacology of ligand sites on delta subunit-containing GABA-A receptorsR01AA021213 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OLSEN, RICHARD W, WALLNER, MARTIN · 2013 to 2019
$1.6M
Mechanisms underlying effects of Hovenia-dihydromyricetin on alcohol intoxicationR21AA017991 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIANG, JING · 2009 to 2010
$415k
Chronic pain and alcohol dependenceR21AA022408 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPIGELMAN, IGOR · 2013 to 2014
$399k
NIAAA NIH HHS R01 AA007680NIAAA NIH HHS R01 AA016100NIAAA NIH HHS R01 AA021213NIAAA NIH HHS R01 AA022448NIAAA NIH HHS R21 AA017991NIAAA NIH HHS R21 AA022408NIAAA NIH HHS R37 AA007680
6 · The paper itself

Abstract

Alcohol (EtOH) intoxication causes changes in the rodent brain

Indexed as

AnimalsEthanolHippocampusMaleNeuronal PlasticityProtein SubunitsRatsRats, Sprague-DawleyReceptors, GABA-AUp-RegulationEthanolGabra2 protein, ratProtein SubunitsReceptors, GABA-A

Identifiers

PMID28536106
PMCPMC5508196
OpenAlexW2617011253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.